Brian Lenz Adma Biologics, Inc. (ADMA) insider trading activity

Brian Lenz is EVP, CFO of ADMA BIOLOGICS, INC.. Currently has a direct ownership of 703,002 shares of ADMA, which is worth approximately $11.5 Million. The most recent transaction as insider was on Mar 07, 2024, when has been sold 16,965 shares (Common Stock) at a price of $6.16 per share, resulting in proceeds of $104,504. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 703K

0% 3M change

8.31% 12M change

Total Value Held $11.5 Million

BRIAN LENZ Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2024	SELL Payment of exercise price or tax liability	$104,504 $6.16 p/Share	16,965 Reduced 2.36%	703,002 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$102,063 $6.12 p/Share	16,677 Reduced 2.26%	719,967 Common Stock
Feb 29 2024	SELL Payment of exercise price or tax liability	$26,451 $5.36 p/Share	4,935 Reduced 0.67%	736,644 Common Stock
Feb 25 2024	SELL Payment of exercise price or tax liability	$43,431 $5.26 p/Share	8,257 Reduced 1.1%	741,579 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$76,424 $4.52 p/Share	16,908 Reduced 2.21%	749,836 Common Stock
Sep 30 2023	SELL Payment of exercise price or tax liability	$54,659 $3.58 p/Share	15,268 Reduced 1.95%	766,744 Common Stock
Aug 16 2023	SELL Open market or private sale	$792,918 $4.45 p/Share	178,184 Reduced 18.56%	782,013 Common Stock
Aug 15 2023	SELL Open market or private sale	$973,258 $4.6 p/Share	211,578 Reduced 21.29%	782,013 Common Stock
Aug 15 2023	SELL Payment of exercise price or tax liability	$2,909,269 $4.61 p/Share	631,078 Reduced 39.66%	960,197 Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	$2,363,045 $2.92 p/Share	809,262 Added 33.71%	1,591,275 Common Stock
Jun 30 2023	SELL Payment of exercise price or tax liability	$56,338 $3.69 p/Share	15,268 Reduced 1.51%	993,591 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$51,202 $3.31 p/Share	15,469 Reduced 1.51%	1,008,858 Common Stock
Mar 07 2023	SELL Payment of exercise price or tax liability	$57,681 $3.4 p/Share	16,965 Reduced 1.63%	1,024,327 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	135,175 Added 11.49%	1,041,292 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$17,750 $3.55 p/Share	5,000 Reduced 0.55%	906,117 Common Stock
Feb 25 2023	SELL Payment of exercise price or tax liability	$32,442 $3.42 p/Share	9,486 Reduced 1.03%	911,117 Common Stock
Jan 04 2023	SELL Payment of exercise price or tax liability	$442,039 $3.87 p/Share	114,222 Reduced 11.04%	920,603 Common Stock
Dec 09 2022	BUY Open market or private purchase	$19,999 $2.86 p/Share	6,993 Added 0.67%	1,034,825 Common Stock
Sep 30 2022	SELL Payment of exercise price or tax liability	$179,038 $2.43 p/Share	73,678 Reduced 6.69%	1,027,832 Common Stock
May 11 2022	SELL Payment of exercise price or tax liability	$74,310 $1.43 p/Share	51,965 Reduced 4.51%	1,101,510 Common Stock
Mar 23 2022	SELL Payment of exercise price or tax liability	$54,280 $1.46 p/Share	37,178 Reduced 3.12%	1,153,475 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	-	137,500 Added 10.35%	1,190,653 Common Stock
Oct 25 2021	BUY Open market or private purchase	$30,000 $1.0 p/Share	30,000 Added 2.74%	1,065,501 Common Stock
Sep 29 2021	BUY Grant, award, or other acquisition	-	900,000 Added 46.5%	1,035,501 Common Stock
Feb 25 2021	BUY Grant, award, or other acquisition	-	63,936 Added 31.34%	140,078 Common Stock

Brian Lenz

EVP, CFO

Ramsey, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Value

Insider Trading

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

Operation

Value

Type

News

Receive news related to ADMA BIOLOGICS, INC.

Track Activities on ADMA

Account